Cardiomyopathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For the main patient (called the "Proband"):
- You are 18 years of age or older
- A doctor has confirmed you have a specific type of heart condition called non-ischemic dilated cardiomyopathy (a weakened, enlarged heart not caused by blocked arteries), where your heart's pumping function measured at 45% or below at some point in your care
- You have at least one living adult close family member (parent, child, or sibling) who could also participate
- You are able to give your agreement to take part in the study
For close family members (called "First-Degree Relatives" or FDRs):
- You are 18 years of age or older and are a parent, child, or sibling of the main patient
- The main patient has already agreed to take part in the study
- You are able to give your verbal agreement to participate
- You have access to a smartphone or tablet with mobile data or Wi-Fi
Who may not be able to join:
For the main patient:
- Your heart condition is caused by something other than non-ischemic dilated cardiomyopathy, as judged by the study doctor
- You have already told your close family members to get their hearts checked
- Your weakened heart is due to blocked or narrowed arteries, a past heart attack, or certain test results suggesting reduced blood flow to the heart
- You have a moderate or severe heart valve problem that is not related to your heart muscle condition
- You were born with a structural heart defect
- You have severe high blood pressure that is not being treated or cannot be treated
- Your heart condition is caused by a temporary or reversible issue, such as an abnormal heart rhythm, a thyroid problem, or iron build-up in the body
- Your reduced heart function is linked to other causes such as pregnancy, heart inflammation, certain diseases (e.g., amyloidosis or sarcoidosis), alcohol, drug use, or chemotherapy
- (For certain study locations only) You live too far away to travel to the study site
For close family members:
- You have already been told to get cardiac screening or have already had a heart ultrasound (echocardiogram) for screening purposes
- You have already been diagnosed with a reduced heart pumping function
- (For certain study locations only) You live too far away to travel to the study site
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Roy Small, MD, Penn Medicine / Lancaster General Hospital
Phone: 717-544-1777
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
This study's primary endpoint is to assess the feasibility of performing AI-EKG test and the subsequent uptake of cardiac screening in FDR of DCM patients.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.